QQ客服 官方微博 反馈留言

	miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1
	Zhang, Haifeng[1]; Hu, Baoli[2]; Wang, Zuopei[3]; Zhang, Feng[4]; Wei, Haitao[5]; Li, Li[6]
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2017
卷号	80期号:5页码:973-984
关键词	MiR-181c DDP resistance NSCLC WIF1 Wnt/beta-catenin pathway
ISSN号	0344-5704
DOI	http://dx.doi.org/10.1007/s00280-017-3435-1
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000414762300010
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5182678
专题	河南大学
作者单位	1.[1]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, Kaifeng 475000, Peoples R China. 2.[2]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, Kaifeng 475000, Peoples R China. 3.[3]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, Kaifeng 475000, Peoples R China. 4.[4]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, Kaifeng 475000, Peoples R China. 5.[5]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, Kaifeng 475000, Peoples R China. 6.[6]Henan Univ, Sch Nursing, Jinming Campus, Kaifeng 475000, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Haifeng[1],Hu, Baoli[2],Wang, Zuopei[3],et al. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2017,80(5):973-984.
APA	Zhang, Haifeng[1],Hu, Baoli[2],Wang, Zuopei[3],Zhang, Feng[4],Wei, Haitao[5],&Li, Li[6].(2017).miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.CANCER CHEMOTHERAPY AND PHARMACOLOGY,80(5),973-984.
MLA	Zhang, Haifeng[1],et al."miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1".CANCER CHEMOTHERAPY AND PHARMACOLOGY 80.5(2017):973-984.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。